scholarly journals Measurements of the upper body ultraviolet exposure to golfers: non-melanoma skin cancer risk, and the potential benefits of exposure to sunlight

2009 ◽  
Vol 25 (6) ◽  
pp. 317-324 ◽  
Author(s):  
Nathan J. Downs ◽  
Peter W. Schouten ◽  
Alfio V. Parisi ◽  
Joanna Turner
Keyword(s):  
Skin Cancer ◽  
Cancer Risk ◽  
Upper Body ◽  
Ultraviolet Exposure ◽  
Skin Cancer Risk ◽  
Non Melanoma Skin Cancer ◽  
Potential Benefits ◽  
Melanoma Skin

scholarly journals Use of hydrochlorothiazide and risk of skin cancer: a nationwide Taiwanese case–control study

2019 ◽  
Vol 121 (11) ◽  
pp. 973-978 ◽  
Author(s):  
Anton Pottegård ◽  
Sidsel Arnspang Pedersen ◽  
Sigrun Alba Johannesdottir Schmidt ◽  
Chaw-Ning Lee ◽  
Chao-Kai Hsu ◽  
...  
Keyword(s):  
Skin Cancer ◽  
Cancer Risk ◽  
Asian Population ◽  
Case Control ◽  
Sensitivity Analyses ◽  
Research Database ◽  
Lip Cancer ◽  
Skin Cancer Risk ◽  
Non Melanoma Skin Cancer ◽  
Melanoma Skin

Abstract Background The antihypertensive agent hydrochlorothiazide has been associated with increased risks of non-melanoma skin cancer (NMSC) and possibly some melanoma subtypes. Previous studies were, however, conducted in predominantly Caucasian populations. We therefore examined the association between hydrochlorothiazide and skin cancer risk in an Asian population. Methods By using Taiwan’s National Health Insurance Research Database (NHIRD), we conducted three separate case–control studies of lip cancer, non-lip non-melanoma skin cancer and melanoma. Cases (n = 29,082) with a first-ever skin cancer diagnoses (2008–2015) were matched 1:10 to population controls. We estimated odds ratios (ORs) associating hydrochlorothiazide use with skin cancer risk by using conditional logistic regression. Results Hydrochlorothiazide use showed no overall association with any of the three outcomes: ORs for high cumulative use of HCTZ (≥50,000 mg) were 0.86 (95% CI 0.09–7.81) for lip cancer, 1.16 (95% CI 0.98–1.37) for non-lip NMSC and 1.07 (95% CI 0.65–1.76) for melanoma. There was some evidence of a dose–response pattern for non-lip NMSC, with an OR of 1.66 (95% CI 0.82–3.33) for 100,000–149,999 mg of HCTZ. The null findings were robust across subgroup and sensitivity analyses. Conclusion Use of HCTZ appears safe in terms of skin cancer risk in an Asian population.

Non-melanoma skin cancer risk in the Queensland renal transplant population

2002 ◽  
Vol 147 (5) ◽  
pp. 950-956 ◽  
Author(s):  
H.M. Ramsay ◽  
A.A. Fryer ◽  
C.M. Hawley ◽  
A.G. Smith ◽  
D.L. Nicol ◽  
...  
Keyword(s):  
Skin Cancer ◽  
Renal Transplant ◽  
Cancer Risk ◽  
Skin Cancer Risk ◽  
Non Melanoma Skin Cancer ◽  
Melanoma Skin

scholarly journals P691 UV exposure and skin type are more important than thiopurine exposure for non-melanoma skin cancer risk in IBD

2017 ◽  
Vol 11 (suppl_1) ◽  
pp. S433-S434
Author(s):  
Y. Wu ◽  
S. Ghaly ◽  
S. Kerr ◽  
K. Krishnaprasad ◽  
R. Prosser ◽  
...  
Keyword(s):  
Skin Cancer ◽  
Cancer Risk ◽  
Skin Type ◽  
Uv Exposure ◽  
Skin Cancer Risk ◽  
Non Melanoma Skin Cancer ◽  
Melanoma Skin

scholarly journals Reducing Non‐Melanoma Skin Cancer Risk in Renal Transplant Recipients

Nephrology ◽  
2021 ◽  
Author(s):  
Zaw Thet ◽  
Alfred K. Lam ◽  
Dwarakanathan Ranganathan ◽  
Soe Yu Aung ◽  
Thin Han ◽  
...  
Keyword(s):  
Skin Cancer ◽  
Renal Transplant ◽  
Cancer Risk ◽  
Renal Transplant Recipients ◽  
Transplant Recipients ◽  
Skin Cancer Risk ◽  
Non Melanoma Skin Cancer ◽  
Melanoma Skin

Glutathione S-transferase and CYP1A1 gene polymorphisms and non-melanoma skin cancer risk in Italian transplanted patients

2006 ◽  
Vol 15 (12) ◽  
pp. 958-965 ◽  
Author(s):  
Macarena Gomez Lira ◽  
Lisa Provezza ◽  
Giovanni Malerba ◽  
Luigi Naldi ◽  
Giuseppe Remuzzi ◽  
...  
Keyword(s):  
Skin Cancer ◽  
Cancer Risk ◽  
Gene Polymorphisms ◽  
Glutathione S Transferase ◽  
Skin Cancer Risk ◽  
Non Melanoma Skin Cancer ◽  
Cyp1a1 Gene ◽  
Melanoma Skin
Sign in / Sign up

Export Citation Format

Share Document